Analyst Price Targets — NOTV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 4, 2025 1:45 pm | Frank Takkinen | Lake Street | $3.00 | $0.86 | TheFly | Inotiv price target lowered to $3 from $5 at Lake Street |
| December 4, 2024 1:57 pm | Frank Takkinen | Loop Capital Markets | $6.00 | $4.15 | StreetInsider | Inotiv Inc. (NOTV) PT Raised to $6 at Lake Street Capital Markets |
| September 30, 2024 7:38 am | Frank Takkinen | Loop Capital Markets | $4.00 | $1.72 | StreetInsider | Lake Street Capital Markets Upgrades Inotiv Inc. (NOTV) to Buy |
| January 24, 2023 12:00 am | David Windley | Jefferies | $8.00 | $6.79 | Pulse 2.0 | Inotiv Stock Receives A $8 Price Target (NOTV) |
| January 11, 2023 9:13 am | — | Lake Street | $10.00 | $6.92 | Benzinga | Lake Street Upgrades Inotiv to Buy, Raises Price Target to $10 |
Latest News for NOTV
WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, is providing public notice regarding its cybersecurity incident that it became aware of on August 8, 2025.
Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript
WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q1 FY 2026”) ended December 31, 2025.
WEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2026 first quarter ended December 31, 2025, on Monday,…
Inotiv (NASDAQ: NOTV - Get Free Report) and Ernexa Therapeutics (NASDAQ: ERNA - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation. Analyst Ratings This is a breakdown of current
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NOTV.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.